Related Experiment Video
Updated: Aug 9, 2026

10:44
Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
Published on: December 9, 2013
Sex Differences in the Developmental Programming of Cardiovascular and Renal Risk across the Lifespan
L E Coats1, N Campbell2, N Shawky Elsayed2
1Department of Obstetrics & Gynecology, University of Mississippi Medical Center, Jackson MS, 39216, USA.
American Journal of Physiology. Renal Physiology
|August 8, 2026
Summary
Maternal health during pregnancy significantly impacts offspring
Area of Science:
- Developmental biology
- Cardiovascular science
- Metabolic disease research
Background:
- Cardiovascular disease is a leading global cause of death.
- Metabolic disorders significantly increase cardiovascular mortality.
- Developmental programming plays a crucial role in long-term cardiac health.
Purpose of the Study:
- To review mechanisms linking impaired fetal growth to long-term cardiometabolic and renal risk.
- To explore the impact of maternal conditions like preeclampsia and obesity on offspring health.
- To discuss emerging therapeutic strategies for prevention.
Main Methods:
- Review of existing literature on developmental origins of health and disease.
- Analysis of preclinical models investigating developmental insults.
- Examination of mechanistic pathways including renin-angiotensin system and oxidative stress.
Main Results:
- Low birth weight is linked to increased adult cardiovascular risk.
- High birth weight is associated with risks of obesity, diabetes, and heart failure.
- Maternal conditions (preeclampsia, obesity) and parental obesity impair fetal growth, increasing offspring's cardiometabolic and renal risk.
Conclusions:
- Maternal health and pregnancy conditions critically influence offspring's lifelong cardiometabolic and renal health.
- Understanding developmental programming is key to preventing future disease.
- Preventive strategies targeting preconception and gestation are needed.
Related Concept Videos
Regulation of the Cardiovascular System
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...